Irix Medical Data has quietly become essential to modern underwriting—but it remains far from universally understood.
Underwriters are being asked to move faster and write more business than ever—without compromising mortality. That’s a tall order, and Irix Medical Data plays a critical role in meeting it.
Yet despite its protective value and widespread adoption, Medical Data is still frequently misunderstood. In this year’s State of the Data webinar, we’ll take a practical, underwriter‑focused look at how this insurtech staple is actually being used across the industry—and where persistent misconceptions continue to get in the way.
Join Chris Martin, Jenna Fariss, and Derek Cole for a clear‑eyed review of the tool that has quietly reshaped modern risk assessment and helped underwriters work faster without sacrificing quality.
In this session, we’ll cover:
- What Medical Data does best—Why underwriters can make a decisive call on most cases in seconds, without additional, slower, and costlier forms of evidence.
- Where Medical Data adds real risk clarity—Practical examples across nicotine dependency, mental health, cancer history, and substance use, and why condition severity matters more than mere presence.
- Common myths, tested against evidence—Juvenile data scarcity, increased decline rates, APS order bumps, and “missing context” … We’ll debunk the untruths, settle the score on what the data actually supports, and show how better insight can expand insurability rather than limit it.
- Advances in interpretation—Condition‑spectrum insights that can make the difference between declining a case and issuing viable business, and how feedback loops are making data more useful, not noisier.
- Live Q&A—Bring your toughest questions.
You’ll walk away with practical ideas for using Medical Data to get a leg up in today’s high-pressure, speed-driven underwriting environment.
Who should attend
Chief executives, actuaries, underwriters, medical directors, underwriting operations and innovation leaders, and others responsible for assessing and managing risk for individual life, long-term care, disability, and Medicare supplement insurance carriers
Chris Martin, MBA
Principal and Managing Director, Milliman IntelliScript
Jenna Fariss, ASA, MAAA
Principal and Consulting Actuary, Milliman IntelliScript
Derek Cole, PharmD
Senior Clinical Consultant, Milliman IntelliScript
